TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SLGL

Sol Gel Technologies Ltd

Healthcare · Biotechnology

72.30$ +4.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLGL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
35.2% 74.5% 75.5% 68.9% 94.7% 91.0% 90.3% 82.5% 92.3% 90.9% 87.3% 90.2%
24.9% 71.5% 63.7% 32.8% 7.6% 15.4% 12.0% 29.0% 26.7% 16.6% 54.4% 36.9%
24.9% 71.5% 63.7% 58.9% 90.4% 82.2% 84.8% 62.5% 72.1% 83.9% 66.7% 80.2%
– – – – – 6.7% 3.6% 18.9% 17.0% 0.8% 10.0% 6.6%
– – – – – 0.0% – 0.0% 0.0% – – –
32.3% 9.5% 7.3% 15.1% 3.7% 7.1% 6.3% 3.7% 3.3% – – –
195.3% 239.7% 385.3% 444.1% 8.3% 14.4% 14.0% 19.6% 9.5% 14.7% 19.5% 23.8%
195.3% 232.1% 379.0% 438.8% 7.0% 10.6% 10.1% 16.9% 7.1% 10.0% 14.7% 20.6%
139.8% 210.3% 339.9% 426.6% – 1.1% 1.1% 1.1% 1.5% 1.0% 1.2% 1.7%
10.4% 3.8% 6.1% 3.5% 4.2% 2.8% 2.0% 1.1% 0.5% 0.3% 3.5% 2.5%
-125.2% -139.7% -285.3% -344.1% 91.7% 85.6% 86.0% 80.4% 90.5% 85.3% 80.5% 76.2%
-1,394.0% -520.6% -579.8% -622.0% -182.9% -248.1% -306.6% -257.5% -414.1% -486.5% -644.1% -792.2%
112.4% 142.3% 106.8% 117.4% 25.6% 31.9% 38.2% 34.1% 49.6% 6.0% 7.8% 9.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?